Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07455513

A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer

This clinical trial evaluates the feasibility of a novel tobacco cessation resource called a Buckeye Quit Stick among smokers with a diagnosed or suspected thoracic cancer. Tobacco use is the single most preventable cause of disease, disability, and death in the United States. While the benefits of quitting smoking are numerous, rates of persistent smoking after cancer diagnosis remain high. Research has found that patients who quit smoking but subsequently relapse frequently report the hand/oral habit as a barrier to sustained smoking cessation. The Buckeye Quit Stick is an innovative cessation aid designed to directly address patients' hand/oral habit by substituting the cessation aid for cigarettes without integrating pharmacologic intervention, which is typically managed by their medical provider and may require direct supervision due to the patient's health status. The Buckeye Quit Stick is designed to satisfy the repeated hand/oral pattern or ritual, thereby avoiding the physical loss of holding a cigarette in the hand or mouth and the action of smoking. It may also help occupy fidgeting hands and potentially reduce stress and cravings. This novel cessation resource may address key factors that influence smoking abstinence and improve patients' health outcomes.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

Location status: Recruiting

Location contact

Logan Roof, MD, MS

CONTACT

[email protected]

614-293-6786

Logan Roof, MD, MS

PRINCIPAL_INVESTIGATOR

About this study

PRIMARY OBJECTIVE:

I. To evaluate the feasibility and acceptability of the Buckeye Quit Stick among 30 patients seen in the Ohio State University (OSU) thoracic clinic(s) and to characterize frequency of use among the accrued sample.

EXPLORATORY OBJECTIVES:

I. Characterizing the population. II. Determining communication preferences, acceptance of the Buckeye Quit Stick, abstinence estimates.

III. Assessing the quality of subjective measures (e.g., anxiety, quality of life, etc.).

IV. Gathering qualitative data to elicit participant feedback regarding the device, The James Comprehensive Cancer Center (CCC) smoking cessation clinic, and overall study design.

OUTLINE:

Patients receive a Buckeye Quit Stick and a smoking cessation informational packet on study. Patients also receive a referral to the James CCC smoking cessation clinic on study.

After completion of study intervention, patients are followed up at 2 weeks, 3 and 6 months, and then up to 24 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • >= 21 years old
  • Speak and understand English
  • Established patient of the OSU thoracic clinics
  • Diagnosed with a thoracic malignancy or has a clinically suspected thoracic malignancy as documented by treating provider
  • Willing and able to participate in the study protocol (e.g., complete the survey and related study documents and provide informed consent)
  • Current self-reported smoker
  • Willingness to change = score of above 1 on the Stages of Change measure

Exclusion criteria

  • < 21 years old (Ohio is a tobacco 21 state.)
  • Patient outside of the OSU clinics (This intervention targets patients who may benefit the most from cessation.)
  • Unwilling or unable to provide consent or complete study components
  • Prisoners will be excluded from participation

Treatment and study plan

Electronic Health Record Review

Other

Ancillary studies

Informational intervention

Other

Receive smoking cessation information

interview

Other

Ancillary studies

Referral

Other

Receive referral

Other names: Referred

Smoking Cessation Intervention

Device

Receive Buckeye Quit Stick

Other names: Smoking and Tobacco Use Cessation Interventions

Survey Administration

Other

Ancillary studies

Primary outcomes

  1. Recruitment rates (feasibility)

    Time frame: Up to 1 year

    To evaluate feasibility, recruitment rates will be defined as the proportion of screened adults accrued relative to those approached in the Ohio State University Comprehensive Cancer Center thoracic oncology clinic.

  2. Adherence (feasibility)

    Time frame: at baseline, 2 weeks, 3 months and 6 months

    Adherence will be assessed by evaluating the proportion of retained participants at each timepoint who complete required study procedures and assessments at each timepoint

  3. Retention rates (feasibility)

    Time frame: At 2 weeks, 3 months, and 6 months

    Retention rates will be defined as the percentage of participants not lost to follow-up at 2-weeks, 3-months and 6-months post-enrollment. Descriptive statistics will be performed.

Study contacts

Contact information is provided by the study sponsor or research team.

The Ohio State University Comprehensive Cancer Center

CONTACT

[email protected]

800-293-5066

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

A Pilot/Feasibility Study of the Buckeye Quit Stick: A Novel Resource for Successful Tobacco Cessation

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 6, 2026
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.